CAS 1345982-69-5

Linerixibat

CAS: 1345982-69-5

Linerixibat

Reinheit: ≥98%

Molekulargewicht: 546.68g/mol

Ref: 54-BUP05499

Linerixibat

CAS: 1345982-69-5

Linerixibat (GSK2330672) is a highly effective, nonabsorbable ASBT inhibitor. Linerixibat can lower glucose in an animal model of type 2 diabetes.

Formel: C₂₈H₃₈N₂O₇S

Reinheit: 98.5% - 99.98%

Farbe und Form: Solid

Molekulargewicht: 546.68

Ref: TM-T3978

Linerixibat

CAS: 1345982-69-5

Formel: C₂₈H₃₈N₂O₇S

Molekulargewicht: 546.68

Ref: 4Z-L-217001

Linerixibat

CAS: 1345982-69-5

Linerixibat is an investigational pharmaceutical compound classified as an ileal bile acid transporter (IBAT) inhibitor. It is derived from chemical synthesis and acts by selectively targeting the IBAT, also known as the apical sodium-dependent bile acid transporter (ASBT), located in the distal ileum of the small intestine. By inhibiting this transporter, Linerixibat reduces the reabsorption of bile acids from the intestinal lumen, which leads to increased fecal bile acid excretion and reduced systemic levels of bile acids.

Formel: C₂₈H₃₈N₂O₇S

Reinheit: Min. 95%

Molekulargewicht: 546.68 g/mol

Ref: 3D-VDC98269